Socio-Demographic, Clinical, and Mortality Differences between HIV-Infected and HIV/HTLV-1 Co-Infected Patients in Peru.
Maria Pia Amanzo-VargasTessy Arellano-VeintemillaElsa González-LagosJuan Ignacio Echevarria ZarateFernando Alonso Mejía CorderoAna GrañaJosé Eduardo Gotuzzo HerenciaPublished in: Pathogens (Basel, Switzerland) (2023)
HIV/HTLV-1 co-infected patients had a significantly shorter survival time compared to HIV-infected patients, suggesting that the immune alterations caused by HTLV-1 in CD4 cell count may have contributed to late initiation of antiretroviral treatment and prophylaxis against opportunistic infections over the decades, and thus reducing their benefits in these patients.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv infected patients
- hiv positive
- human immunodeficiency virus
- hiv aids
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- single cell
- type diabetes
- cardiovascular events
- cardiovascular disease
- stem cells
- hepatitis c virus
- cell therapy
- hiv testing
- bone marrow